呼吸器疾患におけるAIとは、喘息、慢性閉塞性肺疾患（COPD）、肺炎、肺がんなどを含む呼吸器疾患の診断、管理、治療、研究における人工知能（AI）の技術と技術の応用を指します。呼吸器疾患におけるAI市場は、喘息の有病率の上昇や慢性閉塞性肺疾患の症例の増加などの要因により拡大しています。AIアルゴリズムは、胸部X線、CTスキャン、MRIスキャンなどの医療画像を分析して、呼吸器疾患を示す異常を検出できます。その結果、呼吸器疾患におけるAIの需要は、2023年から2030年の予測期間中に国際市場で徐々に増加しました。
AIを活用したデバイスとソフトウェアにより、喘息の症状と服薬遵守を遠隔監視できます。喘息の頻度が増加していることを考慮すると、患者が臨床現場以外で病気を効率的に管理できるように支援できる遠隔モニタリング技術が求められています。人工知能はウェアラブルデバイスからのデータや患者が報告した転帰を分析して、病気の進行や治療の有効性に関する情報を提供できます。アメリカ喘息・アレルギー財団（Asthma and Allergy Foundation of America）によると、アメリカでは毎日平均10人の命が喘息で失われています。2021年、国内では喘息により 3,517人の命が奪われました。さらに、AIは予測分析を活用して喘息の悪化を予測し、積極的な介入が必要な可能性のある高リスク患者を特定できます。呼吸器疾患市場におけるAIを推進するもう1つの重要な要因は、慢性閉塞性肺疾患の症例の増加です。AIアルゴリズムは個々の患者データを分析し、疾患の重症度、併存疾患、治療に対する反応などの要因に基づいて治療計画を調整することができます。この個別化アプローチにより、治療効果を最適化し、副作用を最小限に抑えることができます。また、世界保健機関（WHO）によると、呼吸器疾患による感染症は、年間約300万人が死亡する第3の主要死因とされており、そのうちCOPDによる死亡者の90％近くは、中低所得国の70歳以上で発生しています。また、小児がよく罹患する喘息に罹患している患者数は約2億6,200万人と推定されています。さらに、AI統合呼吸器に関連する技術の進歩と呼吸器疾患の個別治療に対する需要の高まりにより、予測期間中に市場に有利な成長機会が生まれると予想されます。ただし、AIベースのテクノロジーの高コストと運用専門知識の欠如は、2023年から2030年の予測期間を通じて市場全体の成長を妨げるでしょう。
世界の呼吸器疾患におけるAI市場調査で考慮される主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカは、この地域でのAIテクノロジーの研究開発への資金の増加により、2022年に市場を独占しました。資金の増加により、AI研究者、医師、製薬会社、医療機関間のコラボレーションが促進され、データ、スキル、リソースの交換が可能になり、呼吸器疾患管理におけるAI主導の進歩を強化できます。ExecutiveGovによると、2022年にアメリカ政府はAIベースのスマートヘルステクノロジーとデータサイエンスを推進するプログラムを支援するためにAI研究開発に48億米ドルを投資しました。この地域の圧倒的な実績により、呼吸器疾患におけるAIの全体的な需要が促進されると予想されます。さらに、アジア太平洋地域は、この地域の高齢者人口の増加などの要因により、予測期間中に最も急速に成長すると予想されています。高齢患者は複数の併存疾患を抱えていることが多く、非定型的な症状を呈する場合があるため、呼吸器疾患の効果的な管理には早期発見と正確な診断が極めて重要です。AIを活用したツールは、医療従事者が呼吸状態を示すパターンやマーカーを特定するのを支援し、早期介入と個別の治療計画を促進します。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. AI in Respiratory Diseases Market, by Region, 2020-2030 (USD Billion)
1.2.2. AI in Respiratory Diseases Market, by Imaging Type, 2020-2030 (USD Billion)
1.2.3. AI in Respiratory Diseases Market, by Indication, 2020-2030 (USD Billion)
1.2.4. AI in Respiratory Diseases Market, by End Use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global AI in Respiratory Diseases Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global AI in Respiratory Diseases Market Dynamics
3.1. AI in Respiratory Diseases Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Asthma
3.1.1.2. Increasing Cases of Chronic Obstructive Pulmonary Disease
3.1.2. Market Challenges
3.1.2.1. High Cost of AI Based Technology
3.1.2.2. Lack of Operational Expertise
3.1.3. Market Opportunities
3.1.3.1. Technological Advancements Related to AI Integrated Respiratory Devices
3.1.3.2. Growing Demand for Personalized Treatment
Chapter 4. Global AI in Respiratory Diseases Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global AI in Respiratory Diseases Market, by Imaging Type
5.1. Market Snapshot
5.2. Global AI in Respiratory Diseases Market by Imaging Type, Performance - Potential Analysis
5.3. Global AI in Respiratory Diseases Market Estimates & Forecasts by Imaging Type 2020-2030 (USD Billion)
5.4. AI in Respiratory Diseases Market, Sub Segment Analysis
5.4.1. Magnetic Resonance Imaging (MRI)
5.4.2. Computed Tomography (CT) Scan
5.4.3. Electronic Patient-Reported Outcomes (ePRO)
Chapter 6. Global AI in Respiratory Diseases Market, by Indication
6.1. Market Snapshot
6.2. Global AI in Respiratory Diseases Market by Indication, Performance - Potential Analysis
6.3. Global AI in Respiratory Diseases Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. AI in Respiratory Diseases Market, Sub Segment Analysis
6.4.1. Chronic Obstructive Pulmonary Disease
6.4.2. Interstitial Lung Disease
6.4.3. Pulmonary Infection
Chapter 7. Global AI in Respiratory Diseases Market, by End Use
7.1. Market Snapshot
7.2. Global AI in Respiratory Diseases Market by End Use, Performance - Potential Analysis
7.3. Global AI in Respiratory Diseases Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
7.4. AI in Respiratory Diseases Market, Sub Segment Analysis
7.4.1. Hospital
7.4.2. Diagnostic Centers
7.4.3. Ambulatory Surgical Centers
7.4.4. Other End-Users
Chapter 8. Global AI in Respiratory Diseases Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. AI in Respiratory Diseases Market, Regional Market Snapshot
8.4. North America AI in Respiratory Diseases Market
8.4.1. U.S. AI in Respiratory Diseases Market
8.4.1.1. Imaging Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada AI in Respiratory Diseases Market
8.5. Europe AI in Respiratory Diseases Market Snapshot
8.5.1. U.K. AI in Respiratory Diseases Market
8.5.2. Germany AI in Respiratory Diseases Market
8.5.3. France AI in Respiratory Diseases Market
8.5.4. Spain AI in Respiratory Diseases Market
8.5.5. Italy AI in Respiratory Diseases Market
8.5.6. Rest of Europe AI in Respiratory Diseases Market
8.6. Asia-Pacific AI in Respiratory Diseases Market Snapshot
8.6.1. China AI in Respiratory Diseases Market
8.6.2. India AI in Respiratory Diseases Market
8.6.3. Japan AI in Respiratory Diseases Market
8.6.4. Australia AI in Respiratory Diseases Market
8.6.5. South Korea AI in Respiratory Diseases Market
8.6.6. Rest of Asia Pacific AI in Respiratory Diseases Market
8.7. Latin America AI in Respiratory Diseases Market Snapshot
8.7.1. Brazil AI in Respiratory Diseases Market
8.7.2. Mexico AI in Respiratory Diseases Market
8.8. Middle East & Africa AI in Respiratory Diseases Market
8.8.1. Saudi Arabia AI in Respiratory Diseases Market
8.8.2. South Africa AI in Respiratory Diseases Market
8.8.3. Rest of Middle East & Africa AI in Respiratory Diseases Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Siemens Healthineers AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. GE HealthCare Technologies, Inc.
9.3.3. Verily Life Sciences LLC
9.3.4. Philips Healthcare
9.3.5. Dectrocel Healthcare And Research Pvt. Ltd.
9.3.6. Icometrix NV
9.3.7. Infervision UK LTD.
9.3.8. PneumoWave Inc.
9.3.9. Respiray LLC
9.3.10. Thirona B.V.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global AI in Respiratory Diseases Market, report scope
TABLE 2. Global AI in Respiratory Diseases Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global AI in Respiratory Diseases Market estimates & forecasts by Imaging Type 2020-2030 (USD Billion)
TABLE 4. Global AI in Respiratory Diseases Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 5. Global AI in Respiratory Diseases Market estimates & forecasts by End Use 2020-2030 (USD Billion)
TABLE 6. Global AI in Respiratory Diseases Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global AI in Respiratory Diseases Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global AI in Respiratory Diseases Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global AI in Respiratory Diseases Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global AI in Respiratory Diseases Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global AI in Respiratory Diseases Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global AI in Respiratory Diseases Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global AI in Respiratory Diseases Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global AI in Respiratory Diseases Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global AI in Respiratory Diseases Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia AI in Respiratory Diseases Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA AI in Respiratory Diseases Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of Global AI in Respiratory Diseases Market
TABLE 71. List of primary sources, used in the study of Global AI in Respiratory Diseases Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global AI in Respiratory Diseases Market, research methodology
FIG 2. Global AI in Respiratory Diseases Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global AI in Respiratory Diseases Market, key trends 2022
FIG 5. Global AI in Respiratory Diseases Market, growth prospects 2023-2030
FIG 6. Global AI in Respiratory Diseases Market, porters 5 force model
FIG 7. Global AI in Respiratory Diseases Market, pest analysis
FIG 8. Global AI in Respiratory Diseases Market, value chain analysis
FIG 9. Global AI in Respiratory Diseases Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global AI in Respiratory Diseases Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global AI in Respiratory Diseases Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global AI in Respiratory Diseases Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global AI in Respiratory Diseases Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global AI in Respiratory Diseases Market, regional snapshot 2020 & 2030
FIG 15. North America AI in Respiratory Diseases Market 2020 & 2030 (USD Billion)
FIG 16. Europe AI in Respiratory Diseases Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific AI in Respiratory Diseases Market 2020 & 2030 (USD Billion)
FIG 18. Latin America AI in Respiratory Diseases Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa AI in Respiratory Diseases Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
